FDA, CMS To Standardize Regulatory Analytical Tools
This article was originally published in The Gray Sheet
Executive Summary
FDA, CMS and other agencies within the Department of Health and Human Services will combine forces to improve and standardize analytical tools used in regulatory decision-making.